Compounds > freedom
Page last updated: 2024-08-23

freedom and Eczema, Atopic

freedom has been researched along with Eczema, Atopic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thomson, J; Wernham, AGH; Williams, HC2
Thyssen, JP1
de Bruin-Weller, M; Graham, NMH; Pirozzi, G; Shumel, B1
Schmitt, J1
Blauvelt, A; Shumel, B1

Other Studies

6 other study(ies) available for freedom and Eczema, Atopic

ArticleYear
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.
    The British journal of dermatology, 2018, Volume: 178, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatitis, Atopic; Double-Blind Method; Eczema; Freedom; Humans; Severity of Illness Index; Treatment Outcome

2018
Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?
    The British journal of dermatology, 2018, Volume: 178, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Conjunctivitis; Cyclosporine; Dermatitis, Atopic; Freedom; Humans; Interleukin-17

2018
Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors.
    The British journal of dermatology, 2018, Volume: 178, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Conjunctivitis; Cyclosporine; Dermatitis, Atopic; Freedom; Humans; Interleukin-17

2018
After the approval of dupilumab for moderate-to-severe atopic dermatitis: what is next on the research agenda?
    The British journal of dermatology, 2018, Volume: 178, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Freedom; Humans

2018
Response to Critical appraisal of LIBERTY AD CHRONOS: reply from authors.
    The British journal of dermatology, 2018, Volume: 179, Issue:6

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatitis, Atopic; Eczema; Freedom; Humans

2018
Response to critical appraisal of LIBERTY AD CHRONOS.
    The British journal of dermatology, 2018, Volume: 179, Issue:6

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatitis, Atopic; Eczema; Freedom; Humans

2018